Vanguard Group Inc - Feb 28, 2025 SCHEDULE 13G/A Report for Neurocrine Biosciences Inc Common Stock (NBIX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Neurocrine Biosciences Inc Common Stock
Symbol: NBIX
Shares outstanding: 99.8M shares
Disclosed Ownership: 10.1M shares
Ownership: 10.2%
Form type: SCHEDULE 13G/A
Date filed: 3/6/2025, 02:09 PM
Date of event: Feb 28, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10.15%	10.1M	0	66.1K	Ashley Grim	Head of Global Fund Administration